Monoclonal Antibody IV Therapy

All of our offices will open at their normal time on Tuesday, January 21, 2025. We are closely monitoring weather conditions and will provide updates if there are any changes.

We no longer can provide Monoclonal Antibody Infusion due to the FDA withdrawal of the approval.

In nonhospitalized patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease, Remdesivir should be started within 7 days of symptom onset and administered for 3 days.

For more information, please contact our IV Therapy Department at 843.758.0044

Corporate Office:

201 South Fifth Street
Hartsville, SC 29550
843-857-0111

This health center is a Health Center Program grantee under 42 U.S.C. 254b, and a deemed Public Health Service employee under 42 U.S.C. 233(g)-(n). This health center receives HHS funding and has Federal PHS deemed status with respect to certain health or health-related claims, including medical malpractice claims, for itself and its covered individuals. Privacy Policy

All of our offices will open at their normal time on Tuesday, January 21, 2025. We are closely monitoring weather conditions and will provide updates if there are any changes.

Monoclonal Antibody IV Therapy

Error Message